biomedicina slovenica


"Antibodies" : 1980

  1. Faust Helena; Artemchuk Hanna; Triglav Tina K.; Oštrbenk Anja; Poljak Mario; Dillner J.
    Seropositivity to multiple HPV types as a surrogate marker for current infection
    2017
  2. Artemchuk Hanna; Triglav Tina K.; Oštrbenk Anja; Poljak Mario; Dillner J.; Faust Helena
    Presence of antibodies to HPV is highly correlated with presence of HPV DNA
    2017
  3. Oblak Teja; Lindič Jelka; Gubenšek Jakob; Kveder Radoslav; Aleš Andreja; Škoberne Andrej; Večerić-Haler Željka; Borštnar Špela; Avguštin Nuša; Ponikvar Rafael; Mlinšek Gregor; Ferluga Dušan; Kojc Nika; Godnov Uroš; Kovač Damjan
    Treatment of antibody-mediated rejection of kidney grafts with bortezomib and/or rituximab compared to standard regimen
    2017
  4. Razpotnik Rok; Novak Neža; Čurin-Šerbec Vladka; Rajčević Uroš
    Targeting malignant brain tumors with antibodies
    2017
  5. Salvadori Claudia; Švara Tanja; Rocchigiani Guido; Millanta Francesca; Pavlin Darja; Čemažar Maja; Lampreht Tratar Urša; Serša Gregor; Tozon Nataša; Poli Alessandro
    Effects of electrochemotherapy with cisplatin and peritumoral IL-12 gene electrotransfer on canine mast cell tumors
    2017
  6. Maličev Elvira; Maček Marjeta; Klemenc Polona; Rožman Primož
    The level of heparin-induced antibodies in correlation with the result of the flow cytometric functional assay in the patients with suspected HIT
    2017
  7. Ogrič Manca; Terčelj Matic; Praprotnik Sonja; Tomšič Matija; Božič Borut; Sodin-Šemrl Snežna; Čučnik Saša
    Detection of adalimumab and anti-adalimumab antibodies in patients with rheumatoid arthritis
    2017
  8. Ariño Helena; Höftberger Romana; Gresa-Arribas Nuria; Martínez-Hernández Eugenia; Armangue Thaís; Kruer Michael C.; Arpa Javier; Domingo Julio; Rojc Bojan; Bataller Luis; Saiz A.; Dalmau Josep; Graus Francesc
    Paraneoplastic neurological syndromes and glutamic acid decarboxylase antibodies
    2015
  9. Rojc Bojan
    Avtoimuni encefalitis, povzročeni s protitelesi proti membranskim in sinaptičnim antigenom
    [Autoimmune encephalitis caused by antibodies to membrane and synaptic antigens]
    2017
  10. Žigon Polona
    Emerging potentials of antiprothrombin antibodies for APS diagnostic needs
    2017
  11. Marovt Maruška; Marko Pij B.
    Subacute cutaneous lupus erythematosus - paraneoplastic to gastric adenocarcinoma?
    2017
  12. Fishman Dmytro; Kisand Kal; Hertel Christina; Rother Mike; Remm Anu; Pihlap Maire; Adler Priit; Vilo Jaak; Peet Aleksandr; Trebušak Podkrajšek Katarina; Battelino Tadej
    Autoantibody repertoire in APECED patients targets two distinct subgroups of proteins
    2017
  13. Turnšek Hitij Nina; Kern Izidor; Sadikov Aleksander; Knez Lea; Stanič Karmen; Zwitter Matjaž; Čufer Tanja
    Immunohistochemistry for EGFR mutation detection in non-small-cell lung cancer
    2017
  14. Kos Špela; Vanvarenberg Kevin; Dolinšek Tanja; Čemažar Maja; Jelenc Jure; Préat Véronique; Serša Gregor; Vandermeulen Gaëlle
    Gene electrotransfer into skin using noninvasive multi-electrode array for vaccination and wound healing
    2017
  15. Bogožalec Košir Alexandra; Lukan Tjaša; Kukovec Mateja; Snoj Vivijana; Montanič Sendi; Čurin-Šerbec Vladka; Rajčević Uroš
    New monoclonal antibodies against bilitranslocase as a diagnostic tool in determining the progress of clear cell renal cell carcinoma
    [Novi monoklonski protitelesi proti bilitranslokazi kot diagnostično orodje pri ugotavljanju napredovanja svetloceličnega karcinoma ledvičnih celic]
    2017
  16. Rajer Mirjana
    Prognostic and predictive value of PD-L1 in patients with lung cancer
    2017
  17. Ihan Alojz
    Preprečevanje infekcijskih bolezni s cepljenjem
    [Infectious diseases prevention through vaccination]
    2017
  18. Hofheinz Ralf-Dieter; Deplanque Gaël; Komatsu Yoshito; Kobayashi Yoshimitsu; Ocvirk Janja; Racca Patrizia; Guenther Silke; Zhang Jun; Lacouture Mario E.; Jato Eminah
    Recommendations for the prophylactic management of skin reactions induced by epidermal growth factor receptor inhibitors in patients with solid tumors
    2016
  19. Kandolf Sekulović Lidija; Peris Ketty; Hauschild Axel; Stratigos A.; Grob J. J.; Nathan Paul D.; Dummer R.; Forsea A.-M.; Hoeller C.; Ocvirk Janja
    More than 5000 patients with metastatic melanoma in Europe per year do not have access to recommended first-line innovative treatments
    2017
  20. Mulvey Claire M; Breckels Lisa M; Geladaki Aikaterini; Kočevar Britovšek Nina; Nightingale Daniel J H; Christoforou Andy; Elzek Mohamed; Deery Michael J; Gatto Laurent; Lilley Kathryn S
    Using hyperLOPIT to perform high-resolution mapping of the spatial proteome
    2017
  21. Amengual Olga; Forastiero R.; Sugiura-Ogasawara M.; Otomo K.; Oku Kenji; Favas C.; Delgado Alves J.; Žigon Polona; Ambrožič Aleš; Tomšič Matija
    Evaluation of phosphatidylserine-dependent antiprothrombin antibody testing for the diagnosis of antiphospholipid syndrome
    2017
  22. Hočevar Alojzija; Ostrovršnik Jaka; Žigon Polona; Čučnik Saša; Rotar Žiga; Tomšič Matija
    Antiphospholipid antibodies in adult IGA vasculitis
    2017
  23. Artemchuk H.; Triglav Tina K.; Oštrbenk Anja; Elfström K. Miriam; Faust Helena; Poljak Mario; Dillner J.
    Effect of serum antibodies against human papillomavirus type 16 (HPV16) on HPV16 infections
    2017
  24. Smarrazzo Andrea; Mišak Zrinjka; Costa Stefano; Mičetić-Turk Dušanka; Abu-Zekry Mona; Kansu Aydan; Abkari Abdelhak; Bouziane-Nedjadi Karim; Hariz M. Ben; Roma Eleftheria; Velmishi Virtut; Legarda Tamara Maria; Attard Thomas; Djurisic Veselinka; Greco Luigi; Magazzu Giuseppe
    Diagnosis of celiac disease and applicability of ESPGHAN guidelines in Mediterranean countries: a real life prospective study
    2017
  25. Zupančič Daša; Terčelj-Zorman Marjeta; Štrus Bojan; Veranič Peter
    How to obtain goodmorphology and antigen detection in the same tissue section?
    2017
  26. Žigon Polona; Ambrožič Aleš; Tomšič Matija; Sodin-Šemrl Snežna; Čučnik Saša
    Antiphospholipid antibodies in association to adverse pregnancy outcome
    2016
  27. Žigon Polona; Ambrožič Aleš; Tomšič Matija; Sodin-Šemrl Snežna; Čučnik Saša
    Antiprothrombin antibodies in the diagnosis of APS
    2016
  28. Ogrič Manca; Praprotnik Sonja; Sodin-Šemrl Snežna; Čučnik Saša
    Imunogenost zaviralcev dejavnika tumorske nekroze alfa
    [Immunogenicity of tumour necrosis factor alpha inhibitors]
    2016
  29. Žigon Polona; Podovšovnik Anuška; Ambrožič Aleš; Tomšič Matija; Hočevar Alojzija; Gašperšič Nataša; Rotar Žiga; Praprotnik Sonja; Sodin-Šemrl Snežna; Čučnik Saša
    Association of Conventional Risk Factors and Antiphospholipid Antibodies to thrombosis in patients with autoimmune diseases
    2016
  30. Hočevar Alojzija; Ostrovršnik Jaka; Žigon Polona; Čučnik Saša; Rotar Žiga; Tomšič Matija
    Antiphospoholipid antibodies in adult iga vasculitis
    2016
  31. Hočevar Alojzija; Ješe Rok; Rotar Žiga; Žigon Polona; Čučnik Saša; Tomšič Matija
    Antiphospoholipid antibodies in giant cell arteritis. What can they tell us?
    2016
  32. Kveder Tanja; Lakota Katja; Švec Tinka; Čučnik Saša; Žigon Polona; Ambrožič Aleš; Sodin-Šemrl Snežna; Božič Borut; Tomšič Matija
    Fluorometric immunoassay for detection of anti-dsDNA antibodies
    [Dosage immunologique fluorométrique pour la détection d'anticorps anti-adndb]
    2015
  33. Kärner Jaanika; Pihlap Maire; Ranki Annamari; Krohn Kai; Trebušak Podkrajšek Katarina; Bratanič Nevenka; Battelino Tadej; Willcox Nick; Peterson Pärt; Kisand Kai
    IL-6-specific autoantibodies among APECED and thymoma patients
    2016
  34. Meyer Steffen; Woodward Mark; Hertel Christina; Vlaicu Philip; Haque Yasmin; Trebušak Podkrajšek Katarina; Battelino Tadej; Bratanič Nevenka
    AIRE-deficient patients harbor unique high-affinity disease-ameliorating autoantibodies
    2016
  35. Žigon Polona; Podovšovnik Anuška; Ambrožič Aleš; Tomšič Matija; Hočevar Alojzija; Gašperšič Nataša; Rotar Žiga; Praprotnik Sonja; Sodin-Šemrl Snežna; Čučnik Saša
    Added value of anti-phosphatidylserine/prothrombin antibodies for antiphospholipid syndome
    2016
  36. Jelen Mateja; Hošnjak Lea; Štunf Špela; Zagožen Anja; Fujs Komloš Kristina; Markočič Petra; Poljak Mario; Seme Katja
    Hepatitis D virus infection in Slovenian patients with chronic hepatitis B virus infection
    2016
  37. Lužnik Zala; Hawlina Marko; Maličev Elvira; Bertolin Marina; Kopitar Andreja Nataša; Ihan Alojz; Ferrari Stefano; Schollmayer Petra
    Effect of cryopreserved amniotic membrane orientation on the expression of limbal mesenchymal and epithelial stem cell markers in prolonged limbal explant cultures
    2016
  38. 19th Annual meeting of the European Society for Clinical Virology, Lisbon, 14-17 September 2016
    2016
  39. Čučnik Saša
    Imunokemijske značilnosti klinično pomembnih protiteles [beta]2-glikoproteinu I
    [Immunochemical properties of clinically relevant anti-[beta]2-glycoprotein I antibodies]
    2016
  40. Peyvandi Flora; Zver Samo
    ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission
    2008
  41. Krähling Verena; Becker Dirk; Rohde Cornelius; Eickmann Markus; Ero&x11F;lu Yonca; Herwig Astrid; Kerber Romy; Kowalski Katharina; Vergara-Alert Júlia; Becker Stephan; Korva Miša; Avšič-Županc Tatjana
    Development of an antibody capture ELISA using inactivated Ebola Zaire Makona virus
    2016
  42. Bizjak Mojca; Bruck Or; Kadunc Darja; Praprotnik Sonja; Shoenfeld Yehuda
    Vaccinations and secondary immune thrombocytopenia with antiphospholipid antibodies by human papillomavirus vaccine
    2016
  43. Bizjak Mojca; Bruck Or; Praprotnik Sonja; Dahan Shani; Shoenfeld Yehuda
    Pancreatitis after human papillomavirus vaccination
    2016
  44. Sill Martin; Schröder Christoph; Shen Ying; Marzoq Aseel; Komel Radovan; Hoheisel Jörg; Nienhüser Henrik; Schmidt Thomas; Kastelic Damjana
    Protein profiling gastric cancer and neighboring control tissues using high-content antibody microarrays
    2016
  45. Žigon Polona; Ambrožič Aleš; Tomšič Matija; Sodin-Šemrl Snežna; Čučnik Saša
    IGA antiphospholipid antibodies present a thrombotic risk in patients with systemic autoimmune diseases
    2016
  46. Fecková Barbora; Kimáková Patrícia; Ilkovičová Lenka; Szentpéteriová Erika; Debeljak Nataša; Solárová Zuzana; Sačková Veronika; Šemeláková Martina; Bhide Mangesh; Solár Peter
    Far-western blotting as a solution to the non-specificity of the anti-erythropoietin receptor antibody
    2016
  47. Raijmakers Reinout; van Beers Joyce J. B. C.; El-Azzouny Mahmoud; Visser Natasja F. C.; Božič Borut; Pruijn Ger J. M.
    Elevated levels of fibrinogen-derived endogenous citrullinated peptides in synovial fluid of rheumatoid arthritis patients
    2012
  48. Premrov Bajuk Blanka; Furlan Tjaša; Černelč Peter; Čeh Marija; Podgornik Helena
    Monoclonal B-cell lymphocytosis in the population of Slovenian region of Lower Carniola
    2016
  49. Matos Erika
    Pomen določanja HER2 statusa pri raku dojke
    2010
  50. Ocvirk Janja
    Osnovni principi citostatskega in biološkega zdravljenja solidnih rakov
    2005
  51. Zakotnik Branko
    Vloga sistemskega zdravljenja v onkologiji
    2005
  52. Wenger M.; Jezeršek Novaković Barbara
    Rituximab maintenance therapy can be safely administered via a rapid infusin protocol
    2008
  53. Kotnik Mojca; Duratović Konjević Amela; Lokar Katarina; Bernot Marjana; Jezeršek Novaković Barbara; Pečnik Tjaša
    Izzivi sodobnih pristopov onkološke zdravstvene nege in zdravljenja
    2009
  54. Gorenc Nataša
    Izkušnje v zdravstveni negi bolnika, zdravljenega z bevacizumabom
    2009
  55. Bernot Marjana
    Zdravstvena nega bolnika pri pojavu neželenih učinkov sistemskega zdravljenja s tarčnim zdravilom bevacizumab
    2009
  56. Umičević Snežana
    Priprava, aplikacija in shranjevanje zdravila bevacizumab
    2009
  57. Ocvirk Janja
    Klinična uporaba zdravila bevacizumab v onkologiji
    2009
  58. Jovchevska Ivana; Kočevar Nina; Kastelic Damjana; Komel Radovan
    Llama heavy-chain antibodies as means to identify protein markers for human glioma
    2013
  59. Maličev Elvira; Kozak Matija; Rožman Primož
    Evaluation of a flow cytometric assay for the confirmation of heparin-induced thrombocytopenia
    2016
  60. Majcen-Vivod Božislava
    Seroprevalence of antibodies to hepatitis A virus in blood donors and patients in Maribor
    2008
  61. Jezeršek Novaković Barbara
    Checkpoint inhibitors in Hodgkin¼s lymphoma
    2016
  62. Škoberne Andrej
    Vloga protiteles proti fosfolipaza A2 receptorju pri patogenezi membranske nefropatije
    [The role of phospholipase A2 receptor autoantibodies in the pathogenesis of membranous nephropathy]
    2014
  63. Haines G. Kenneth; Frković-Grazio Snježana; Bračko Matej
    HER2 in well differentiated breast cancer
    2008
  64. Mičetić-Turk Dušanka; Umek Bradač Stanislava; Gorenjak Maksimiljan
    Ultrasonographic (US) assessment of coeliac disease (CD) in children
    1996
  65. Arvikar Sheila; Collier Deborah S; Fisher Mark C; Unizony Sebastian; Cohen George L; McHugh Gail; Kawai Toshihisa; Strle Klemen; Steere Allen C.
    Clinical correlations with Porphyromonas gingivalis antibody responses in patients with early rheumatoid arthritis
    2013
  66. Londoño Diana; Cadavid Diego; Drouin Elise E.; Strle Klemen; McHugh Gail; Aversa John; Steere Allen C.
    Antibodies to endothelial cell growth factor and obliterative microvascular lesions in the synovium of patients with antibiotic-refractory lyme arthritis
    2014
  67. Crowley Jameson T.; Drouin Elise E.; Pianta Annalisa; Strle Klemen; Wang Qi; Costello Catherine E.; Steere Allen C.
    A highly expressed human protein, apolipoprotein B-100, serves as an autoantigen in a subgroup of patients with lyme disease
    2015
  68. Pianta Annalisa; Drouin Elise E.; Crowley Jameson T.; Arvikar Sheila; Strle Klemen; Costello Catherine E.; Steere Allen C.
    Annexin A2 is a target of autoimmune T and B cell responses associated with synovial fibroblast proliferation in patients with antibiotic-refractory Lyme arthritis
    2015
  69. Darcis Gilles; Kula Anna; Bouchat Sophie; Fujinaga Koh; Corazza Francis; Ait-Ammar Amina; Delacourt Nadège; Melard Adeline; Kabeya Kabamba; Peterlin Matija Boris
    An in-depth comparison of latency-reversing agent combinations in various in vitro and ex vivo HIV-1 latency models identified bryostatin-1+JQ1 and ingenol-B+JQ1 to potently reactivate viral gene expression
    2015
  70. Kenda Jana; Kojović Maja; Graus F.; Gregorič Kramberger Milica
    (Pseudo)hemidystonia associated with anti-glutamic acid decarboxylase antibodies
    2015
  71. Mekinian Arsene; Ambrožič Aleš; Avčin Tadej
    Mothers' antiphospholipid antibodies during pregnancy and the relation to offspring outcome
    2014
  72. Roncador Giovanna; Engel Pablo; Maestre Lorena; Anderson Amanda P.; Cordell Jacqueline L.; Cragg Mark S.; Čurin-Šerbec Vladka; Jones Margaret; Juranić Lisnić Vanda; Kremer Leonor
    The European antibody network's practical guide to finding and validating suitable antibodies for research
    2016
  73. Homšak Matjaž; Koren Brigita; Tomazin Maja; Brunčko Aleksander
    Mehanizmi imunoterapije z alergeni apliciranimi pod jezik (SLIT)
    2008
  74. Božič Mojca; Boc Vinko; Salapura Vladka; Blinc Aleš; Stegnar Mojca
    Is restenosis/reocclusion after femoropopliteal percutaneous transluminal angioplasty (PTA) the consequence of reduced blood flow, inflammation, and/or hemostasis disturbances?
    2015
  75. Mesti Tanja; Hlebanja Zvezdana; Reberšek Martina; Volk Neva; Benedik Jernej; Boc Marko; Ocvirk Janja
    Joint pain in patients with metastatic colorectal cancer (mCRC) treated with bevacizumab
    2009
  76. Fikfak Nataša; Mesti Tanja
    Zdravljenje diseminiranega plazmocitoma z bortezomibom
    2008
  77. Ocvirk Janja
    Sistemsko zdravljenje raka debelega črevesa in danke
    [Sistemic treatment of colorectal cancer]
    2009
  78. Grašič-Kuhar Cvetka; Čufer Tanja; Golouh Rastko
    Highly effective treatment with trastuzumab in a chemotherapy-resistant metastatic breast carcinoma
    2002
  79. Glišovič Maša; Mršnik Marina; Zupanič Slavec Zvonka
    Celiakija - spoznavanje bolezni v svetu in pri Slovencih
    [The evolution of coeliac disease]
    2015
  80. Žigon Polona; Čučnik Saša; Ambrožič Aleš; Sodin-Šemrl Snežna
    Diagnostic efficacy of antiphosphatidylserine/prothrombin antibodies (aPS/PT) for antiphospholipid syndrome
    2012
  81. Ciuleanu Tudor; Ocvirk Janja
    A randomized, open-label CECOG phase II study evaluating the efficacy and safety of FOLFOX6 + cetuximab versus FOLFIRI + cetuximab as first-line therapy in patients (pts) with metastatic colorectal cancer (mCRC)
    2008
  82. Mesti Tanja; Ocvirk Janja
    Evaluation of the glioblastoma cell lines response to arsenic trioxide (As [sub] 2O [sub] 3) and bevacizumab according to the IDH1 mutation status
    [Odgovor glioblastomskih celičnih linij na arzenov trioksid (As [spodaj] 2O [spodaj] 3) in bevacizumab glede na prisotnost IDH1 mutacije]
    2015
  83. Gardašević Topčić Ivana; Jaki Polona; Pahor Dušica
    Učinki intravitrealnega bevacizumaba na morfologijo in delovanje mrežnice pri zdravljenju zapore centralne mrežnične vene
    2015
  84. Lanišnik-Rižner Tea; Sasano Hironobou; Choi Man Ho; Odermatt Alex; Adamski Jerzy
    Recommendations for description and validation for antibodies for research use
    2015
  85. Žigon Polona; Božič Mojca; Frank Mojca; Ambrožič Aleš; Tomšič Matija; Hočevar Alojzija; Božič Borut; Sodin-Šemrl Snežna; Kveder Tanja; Čučnik Saša
    Laboratory methodology important in the diagnosis and prognosis of antiphospholipid syndrome
    2015
  86. Štrbenc Malan; Smerdu Vika; Županc Manca; Tozon Nataša; Fazarinc Gregor
    Pattern of myosin heavy chain isoforms in different fibre types of canine trunk and limb skeletal muscles
    2004
  87. Lotrič-Furlan Stanka; Rojko Tereza; Jelovšek Mateja; Petrovec Miroslav; Avšič-Županc Tatjana; Lusa Lara; Strle Franc
    Comparison of clinical and laboratory characteristics of patients fulfilling criteria for proven and probable human granulocytic anaplasmosis
    2015
  88. Lelli Davide; Moreno Ana; Steyer Andrej; Naglič Tina; Chiapponi Chiara; Prosperi Alice; Faccin Francesca; Sozzi Enrica; Lavazza Antonio
    Detection and characterization of a novel reassortant mammalian orthoreovirus in bats in Europe
    2015
  89. Rozman Blaž
    The association between circulating antibodies against domain I of beta2-glycoprotein I and thrombosis
    2009
  90. Agmon-Levin Nancy; Rozman Blaž
    Prevalence of hepatitis C serum antibody in autoimmune diseases
    2009
  91. Irman Špela; Škarabot Miha; Muševič Igor; Rozman Blaž; Božič Borut
    The use of atomic force microscopy to study the pathologic effects of anti-annexin autoantibodies
    2011
  92. Sonc Monika
    Biološka zdravila v terapiji raka dojke in ostalih rakih
    2009
  93. Borštnar Simona
    Monoklonska protitelesa v zdravljenju raka dojk
    [Monoclonal antibodies for the treatment of breast cancer]
    2015
  94. Davceva Natasha; Basheska Neli; Balažic Jože
    Diffuse axonal injury - a distinct clinicopathological entity in closed head injuries
    2015
  95. Rajić Vladan; Debeljak Maruša; Goričar Katja; Jazbec Janez
    Polymorphisms in GRIA1 gene are a risk factor for asparaginase hypersensitivity during the treatment of childhood acute lymphoblastic leukemia
    2015
  96. Tepeš Bojan
    Population based Helicobacter pylori screening and eradication
    2014
  97. Podgoršek Daša; Cerar Kišek Tjaša; Logar Mateja; Lešničar Gorazd; Remec-Zafred Tatjana; Baklan Zvonko; Pal Emil; Ružić-Sabljić Eva
    Evaluation of the immunochromatographic (Leptocheck) test for detection of specific antibodies against leptospires
    2015
  98. Pinheiro C.; Roque R.; Adriano A.; Mendes P.; Praça M.; Reis I.; Pereira T.; Srebotnik-Kirbiš Irena; André S.
    Optimization of immunocytochemistry in cytology
    2015
  99. Pečovnik-Balon Breda; Ekart Robert; Gorenjak Maksimiljan
    Fibroblastni rastni faktor 23 in kronična ledvična bolezen
    [Fibroblast growth factor 23 in chronic kidney disease]
    2013
  100. Urlep Žužej Darja; Dolinšek Jernej; Mičetić-Turk Dušanka
    Pomen določanja protiteles proti eksokrinemu delu pankreasa (PAB) pri otrocih in mladostnikih s Crohnovo boleznijo
    2010

1 101 201 301 401 501 601 701 801 901  



New search      Comments      Top of page Institute for Biostatistics and Medical Informatics